Public-Private Partnership Builds Africa’s First Multi-Vaccine Production Plant
European investors have announced their partnership with South African biopharmaceutical company The Biovac Institute in building Africa’s first end-to-end multi-vaccine manufacturing facility in South Africa. Biovac projects to annually produce tens of millions of doses of vaccines for cholera, polio, and pneumonia. The plant will be the continent’s first end-to-end vaccine manufacturing plant, and the […]
Poland, Romania Resist Brussels Court Order to Pay $2.2 Billion to Pfizer
A court in Belgium has ordered Poland and Romania to proceed with paying €1.9 billion ($2.2 billion) for purchasing mRNA COVID-19 shots from Pfizer, Inc. and BioNTech SE in a case brought by Pfizer three years ago. The lawsuit and court judgement has intensified a broader legal dispute over mRNA COVID shot contracts signed by […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
Nipah Virus Cases in Asia Increase Pressure to Develop a Vaccine
On Jan. 26, 2026, the government of India confirmed two cases of Nipah virus (NiV) infection in its state of West Bengal. Both cases involved health care workers in a hospital in the district of North 24 Parganas. One of the individuals died after being hospitalized on Jan. 28. Contact tracing linked a total of […]
Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]